CN Patent
CN109602726A — 托吡酯缓释剂及制备方法
Assigned to ZHUHAI TIANYI MEDICINE TECHNOLOGY DEVELOPMENT Co Ltd · Expires 2019-04-12 · 7y expired
What this patent protects
本发明提供了托吡酯缓释剂,该缓释剂包括托吡酯10~30份、骨架材料5~40份和填充剂40~60份。本发明的托吡酯缓释剂中,所需要用到的辅料种类少,生产成本低,制备方法操作简单,制备条件不苛刻,易于产业化推广。
USPTO Abstract
本发明提供了托吡酯缓释剂,该缓释剂包括托吡酯10~30份、骨架材料5~40份和填充剂40~60份。本发明的托吡酯缓释剂中,所需要用到的辅料种类少,生产成本低,制备方法操作简单,制备条件不苛刻,易于产业化推广。
Drugs covered by this patent
- Topamax (topiramate) · Janssen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.